What Challenges Exist in the Development of Neuroprotective Therapies?
Despite the potential benefits, developing effective neuroprotective therapies faces several challenges:
Blood-Brain Barrier (BBB): Many neuroprotective agents struggle to cross the BBB, limiting their efficacy in targeting the central nervous system. Side Effects: Some agents may have adverse effects or toxicity at therapeutic doses. Complexity of Neurological Disorders: The multifactorial nature of diseases like Alzheimer's and Parkinson's makes it difficult to identify a single therapeutic target.
